Seagen, now part of Pfizer, is a global biotechnology company headquartered in Bothell, WA, dedicated to revolutionizing cancer care through the development of transformative therapies that significantly impact patients' lives. With a focus on antibody-drug conjugates (ADCs), Seagen has been at the forefront of innovative cancer therapeutics for over two decades, committed to addressing challenging clinical needs with safe and effective solutions.
Driven by a mission to make a tangible difference for individuals affected by cancer, Seagen's research efforts are centered on advancing a diverse pipeline of novel therapies for both solid tumors and blood-related cancers. The company's culture emphasizes integrity, collaboration, and diversity, uniting a global team of scientists, clinicians, advocates, and innovators in the shared goal of transforming cancer care and supporting patients and their families throughout their journey.
Generated from the website